Furthermore, we reveal the dual role of Meox1 in driving tumor angiogenesis and suppressing CD8+ T cell infiltration, thereby establishing its therapeutic implications for overcoming immunotherapy resistance. This evidence concerns the gene CD8A and neoplasm.